Cantor Fitzgerald Reiterates VYNE Therapeutics (VYNE) at Overweight with $10 PT, Sees Latest FMX114 Data Underscoring "Positive Investment Thesis"
Go back to Cantor Fitzgerald Reiterates VYNE Therapeutics (VYNE) at Overweight with $10 PT, Sees Latest FMX114 Data Underscoring "Positive Investment Thesis"| (NASDAQ: VYNE) | Delayed: 28.56 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.56 | 52 Week High | $ | |||
| Open | $28.56 | 52 Week Low | $ | |||
| Day High | $28.56 | P/E | N/A | |||
| Day Low | $28.56 | EPS | $ | |||
| Volume | 2,685,854 | |||||

